Icahn Complains of VISX's Blurry Vision

Roberts, Ricardo
November 2000
Mergers & Acquisitions Report;11/13/2000, Vol. 13 Issue 45, p1
Focuses on the complaints of financier Carl Icahn, a financier who owns a stake at VISX Inc. Speculations on the possibility of sale of VISX; Percentage of stakes owned by Icahn; Assessment of the company's performance; Background of the company.


Related Articles

  • Shareholder dialogue key in VISX, Icahn talks. Clancy, David // Ophthalmology Times;06/15/2001, Vol. 26 Issue 12, p1 

    Deals with the controversy between VISX and VISX investor Carl Icahn. Issue on the company's business opPercentage of VISX stock that Icahn owns; Action taken by VISX to deal with the conflict; Significance of communication between the company and its shareholders.

  • In Icahn's Eyes: Laser Co. Should Land Buyer. Roberts, Ricardo // Mergers & Acquisitions Report;10/30/2000, Vol. 13 Issue 43, p1 

    Focuses on the suggestion of Carl Icahn, a shareholder in VISX Inc., that the company should consider looking for acquirors. Why VISX does not need to find a buyer; Products developed by the company; Stock price as of October 30, 2000; Potential buyers.

  • For VISX, WIll Icahn See His Bid Through? Roberts, Ricardo // Mergers & Acquisitions Report;4/30/2001, Vol. 14 Issue 18, p1 

    Reports on the acquisition bid made by Carl Icahn on VISX Inc. Stock valuation of VISX as of 2001; Estimated cost of the acquisition; Other companies acquired by Carl Icahn.

  • VISX Again Lands on Icahn's Activism Plate. Roberts, Ricardo // Mergers & Acquisitions Report;4/21/2003, Vol. 16 Issue 16, p1 

    Reports on the proxy nomination filed by investor Carl Icahn to the board of VISX Inc. on April 10, 2003. Stance taken by the board on the nomination; Stock price trading of the company; Comments from Tim Maier, chief financial officer of VISX.

  • VISX adopts poison-pill plan. Clancy, David // Ophthalmology Times;09/15/2000, Vol. 25 Issue 18, p1 

    Reports that VISX Inc. was spurred into adopting a poison-pill plan after financier Carl Icahn indicated he wished to buy more than $15 million of the company's stock. Significance of the plan; Comments from analysts; Stock trading symbol considered by VISX in the New York Stock Exchange.

  • Icahn offers to buy VISX for $1.9 billion. Dlugoss, Mark L. // Ophthalmology Times;05/15/2001, Vol. 26 Issue 10, p1 

    Reports on the offer of financier Carl Icahn to purchase VISX. Aim of Icahn's move; Price of the stock of VISX; Details of the acquisition offer; Speculations on the offer.

  • Icahn Again Prods VISX. Roberts, Ricardo // Mergers & Acquisitions Report;12/3/2001, Vol. 14 Issue 45, p1 

    Reports on the plan of corporate raider Carl Icahn to nominate his slate of directors to the board of VISX Inc. Comment from Tim Maier, chief financial officer, on the proposal of Icahn; Statement issued by David Harmon, senior editor of 'Market Scope' journal the potential acquiror for VISX.

  • Icahn drops VISX proxy fight. Clancy, David; Dlugoss, Mark L. // Ophthalmology Times;06/01/2001, Vol. 26 Issue 11, p1 

    Reports that financier Carl Icahn dropped his bid to replace the VISX Inc. board of directors with a slate of his own 3 days before the company's 2001 meeting. Icahn's controlling interest in the firm; Stockholders re-elected to VISX board of directors at the 2001 meeting; Statement from VISX...

  • Highlights of interview with VISX's Davila.  // Ophthalmology Times;06/15/2001, Vol. 26 Issue 12, p54 

    Presents excerpts from an interview with Liz Davila, chairman and chief executive officer of VISX, regarding the proxy contest of the company with Carl Icahn and the events leading to the company's annual meeting in May 2001.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics